Profil
Lauren Merendino is currently Chief Commercial Officer at Day One Biopharmaceuticals, Inc. since 2023.
Former roles include Independent Non-Executive Director at ESSA Pharma, Inc. from 2023 to 2025, Vice President-Neurological Rare Diseases at Genentech, Inc. from 2018 to 2021, and Chief Commercial Officer at Myovant Sciences, Inc. and Myovant Sciences Ltd. Education includes an MBA from New York University and an undergraduate degree from The Pennsylvania State University.
Aktive Positionen von Lauren Merendino
| Unternehmen | Position | Beginn |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.06.2023 |
Ehemalige bekannte Positionen von Lauren Merendino
| Unternehmen | Position | Ende |
|---|---|---|
| ESSA PHARMA INC. | Direktor/Vorstandsmitglied | 05.03.2025 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.04.2021 |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Corporate Officer/Principal | - |
| MYOVANT SCIENCES LTD. | Corporate Officer/Principal | - |
Ausbildung von Lauren Merendino
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSA Pharma, Inc.
ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Myovant Sciences Ltd.
Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
















